Print Page Close Window

2019 Press Releases

FILTER:

Keyword Search

April 18, 2019

Ovid Therapeutics to Present at the American Academy of Neurology 71st Annual Meeting

READ MORE

March 28, 2019

Ovid Therapeutics Announces Senior Management Changes to Align Expertise with Advancing Clinical Stage Pipeline

READ MORE

March 21, 2019

Ovid Therapeutics Announces Appointment of Pharmaceutical Veteran, Thomas Perone, as Senior Vice President, General Counsel and Corporate Secretary

READ MORE

March 7, 2019

Ovid Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results

READ MORE

March 4, 2019

Ovid Therapeutics to Present at the Cowen and Company 39th Annual Healthcare Conference on Monday, March 11

READ MORE

February 20, 2019

Ovid Therapeutics Announces Pricing of $30 Million of Securities in Concurrent Public Offerings of Common and Preferred Stock

READ MORE

February 19, 2019

Ovid Therapeutics Announces Proposed Concurrent Public Offerings of Common Stock and Preferred Stock

READ MORE

January 4, 2019

Ovid Therapeutics Outlines 2019 Clinical and Business Priorities

READ MORE